The Serological Profile of Herpes Virus Amongst Patients with Bad Obstetric History

Shweta, B.; Nupur, G.; Archana, A.; Inderjeet, G.; Suman, G.; Manisha, B.; Thakur, D.; Reza, S; Shashi, Kumar

doi:10.1016/j.apme.2015.02.005

Cited by 2 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[9][10][11] Assessing IgM antibodies in maternal sera can signal the acute phase of maternal infection and the probability of congenital transmission of T. gondii. 12 In our research, IgM antibodies were detected in 10 out of 12 (93.3%) patients with HA manifestation, which concurs with other studies reporting approximately 66.3% of T. gondii-infected women demonstrating an IgM response. 13 It is recommended that pregnant women undergo testing for TORCH antibodies, those who experience unfavorable outcomes should take precautions to avoid infection, such as staying away from cat litter, ensuring the meat is thoroughly cooked, and washing their hands after handling raw meat.…”

Section: Discussionsupporting

confidence: 92%

An examination of the seroprevalence of torch infections and their correlation with adverse reproductive outcomes in females exhibiting a bad obstetric history

Al-Karawi,

Mohammed,

Al-Saadi

2023

IJMR

View full text Add to dashboard Cite

: The term TORCH infections refer to a group of diseases including Toxoplasma, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections. These are a set of pathogens capable of traversing the placental barrier, subsequently causing congenital infections. Often these infections are asymptomatic initially and pose significant diagnostic challenges during gestation, potentially leading to undesirable obstetric outcomes. This research intends to explore the correlation between TORCH infections and perinatal outcomes within pregnancies deemed high-risk.: We examined 143 high-risk pregnant patients aged 18-46 from the Obstetrics and Gynecology Department at the Baghdad Gynecology and Obstetrics Hospital. Hundreds of normal pregnancy group were also included. The high-risk group encompassed women with recurring pregnancy loss, fetal congenital anomalies, intrauterine fetal death, and low birth weight intrauterine neonatal death. The presence of IgG and IgM antibodies against TORCH agents in patients’ serum control serum were assessed using ELISA kits. We compared perinatal outcomes between TORCH seropositive and seronegative high-risk pregnant women.: Among the 143 high-risk pregnancies, a significant proportion of young, low-parity women from diverse residences were co-seropositive for Toxoplasma gondii, rubella virus, Cytomegalovirus, and Herpes Simplex infections. Of these, 55 cases (48.4%) were seropositive for all the four TORCH agents compared to 88 cases (38%) were seropositive for antibodies to one to three of the TORCH agents. IgG seropositivity was 74.5%, while IgM seropositivity was 31.8% for Toxoplasma gondii, 3.6% for CMV and 0% for RV infections, respectively. Significantly, high-risk pregnancies with TORCH seropositivities exhibited a clearly strong correlation with Habitual abortions outcomes.: High-risk manifestations demonstrated for Toxoplasma gondii, Rubella virus, Cytomegalovirus and Herpes Simplex infections strongly associated with habitual abortions compare to high but less significant association in those seropositive to one, two or three of the TORCH agents

show abstract